1Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman; 2Medicine Residency Programme, Oman Medical Specialty Board, Muscat, Oman *Corresponding Author’s e-mail: kowhassan@gmail.com االلتهاب الرئوي الناتج عن امليكوبالزما الرئوية مع تدهور يف االنصباب اجلنيب بالرغم من العالج املناسب مبضادات امليكروبات تقرير حالة كوثر سلمان حسن و غالب اخلضوري abstract: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia. As M. pneumoniae pneumonia is usually a mild and self-limiting disease, complications such as pleural effusion occur only rarely. We report a 22-year-old woman who presented to the Emergency Medicine Department of the Sultan Qaboos University Hospital, Muscat, Oman, in 2017 with an eight-day history of fever associated with coughing, chills and rigors. She was diagnosed with M. pneumoniae pneumonia, but subsequently developed pleural effusion which worsened despite treatment with appropriate antimicrobials. The pleural effusion required drainage, which revealed that it was of the more severe exudative type. Following drainage, the patient improved dramatically. She was discharged and advised to continue taking antibiotics. Keywords: Mycoplasma pneumoniae; Bacterial Pneumonia; Pleural Effusion; Antimicrobial Agents; Drainage; Case Report; Oman. امللخ�ص: امليكوبالزما الرئوية هي �شبب �شائع لاللتهاب الرئوي املكت�شب يف املجتمع. مبا اأن اللتهاب الرئوي الناجت عن امليكوبالزما الرئوية هوعادة مر�ض خفيف وحمدود ذاتيًا، فاإن امل�شاعفات مثل الن�شباب اجلنبي ل حتدث اإل نادراً. نعر�ض هنا حالة امراأة تبلغ من العمر 22 عامًا مت اإدخالها اإىل ق�شم طب الطوارئ يف م�شت�شفى جامعة ال�شلطان قابو�ض، م�شقط، ُعمان، يف عام 2017 مع تاريخ مر�شي من احلمى املرتبط بال�شعال والق�شعريرة وق�شوة ملدة ثمانية اأيام. مت ت�شخي�ض اإ�شابتها بالتهاب رئوي ناجت عن امليكوبالزما الرئوية، ولكن تفريغ اإىل اجلنبي الن�شباب احتاج املنا�شبة. امليكروبات مب�شادات العالج من بالرغم �شاء الذي اجلنبي الن�شباب اإىل تطور ذلك بعد والذي ك�شف على اأنه كان من نوع ن�شحي �شديد. بعد التفريغ، حت�شن و�شع املري�شة ب�شكل كبري. ومت ترخي�شها ون�شحت مبوا�شلة تناول امل�شادات احليوية. الكلمات املفتاحية: امليكوبالزما الرئوية؛ اللتهاب الرئوي البكتريي؛ الن�شباب اجلنبي؛ م�شادات اجلراثيم؛ تفريغ؛ تقرير حالة؛ عمان. Mycoplasma pneumoniae Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials Case report *Kowthar S. Hassan1 and Ghalib Al-Khadouri2 Sultan Qaboos University Med J, May 2018, Vol. 18, Iss. 2, pp. e239–242, Epub. 9 Sep 18 Submitted 27 Nov 17 Revision Req. 3 Jan 18; Revision Recd. 29 Jan 18 Accepted 22 Feb 18 casE rEport doi: 10.18295/squmj.2018.18.02.022 Mycoplasma pneumoniae are extremely small self-replicating free-living bacteria which can cause upper respiratory tract infections, including pharyngitis, sinusitis, ear pain, rhinorrhoea and pneumonia.1,2 M. pneumoniae pneu- monia is described as atypical and accounts for 1–29% of community-acquired pneumonia cases.2 The causative bacteria can be transmitted through aerosols as well as in settings which promote close physical contact, such as homes, schools, military barracks and dormitories.3 The post-exposure incub- ation period is between two to three weeks and infections are more prevalent among children and young adults.4 Common risk factors include age (i.e. younger children or older adults), immune status (i.e. immunocompromised individuals with HIV or those undergoing chemotherapy or taking steroids), smoking and pre-existing lung disease.5 Classic symptoms of M. pneumoniae infection include fever, cough and the production of sputum; in most cases, the disease is self-limiting and results in a good prognosis.6 However, M. pneumoniae pneumonia can be life-threatening, resulting in respiratory failure or acute respiratory distress syndrome in certain cases.7 However, pulmonary complications such as parapneu- monic effusion are rare and occur mainly in children and adolescents; most cases are unilateral, low-volume and resolve with appropriate antimicrobial therapy.8–10 M. pneumoniae pneumonia can be diagnosed by serology using an enzyme immunoassay. An acute infection is indicated by the detection of immuno- globulin (Ig) A and/or IgM, with a single titre of Mycoplasma pneumoniae Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials Case report e240 | SQU Medical Journal, May 2018, Volume 18, Issue 2 IgM greater than 1:64 or a four-fold rise in the IgG titre.11,12 Polymerase chain reaction (PCR) analysis can also be used to detect M. pneumoniae in clinical samples of sputum and those of nasopharyngeal and throat swabs. However, microbial testing is not usually performed for outpatients with community-acquired pneumonia because empirical treatment is almost always successful.13 This case report describes a patient with pneumonia who was not initially tested for M. pneumoniae. The patient deteriorated and developed severe pleural effusion, despite the administration of appropriate antimicrobials, necessitating drainage. Case Report A 22-year-old woman presented to the Emergency Medicine Department of the Sultan Qaboos University Hospital (SQUH), Muscat, Oman, in 2017 with an eight-day history of fever associated with coughing, chills and rigors. Although her coughing was initially dry, she had begun producing yellow-green sputum on day five and developed shortness of breath on day seven. The patient reported having recently undertaken a trip one week prior with her classmates, some of whom had also developed coughs. She was known to have the sickle cell trait and vitamin B12 deficiency and was taking weekly cyanocobalamin injections. Upon initial examination, the patient appeared ill, dehydrated, febrile and tachycardic. Her temperature was 40.3 ºC, her heart rate was 134 beats per minute and her respiratory rate was 18 breaths per minute. Pulse oximetry indicated an oxygen saturation of 97% in room air. Auscultation of the chest revealed reduced breath sounds in the right base. The results of initial and serial laboratory investigations are shown in Table 1. A chest X-ray showed consolidation of the right middle and lower lobes, with right-sided pleural effusion and partial lower lobe collapse [Figure 1A]. Subsequently, the patient was diagnosed clinically with community- acquired pneumonia. While awaiting the results of a respiratory viral screening panel and sputum culture, she was prescribed 2 g of ceftriaxone once daily and 500 mg of intravenous azithromycin and 75 mg of oseltamivir twice daily. However, the respiratory viral panel results were negative and the oseltamivir was discontinued. Three days later, the culture results of the sputum sample showed only upper respiratory commensals. Two days after admission, the condition of the patient deteriorated. She was breathless at rest with a respiratory rate of 40 breaths per minute. Her heart rate had decreased to 120 beats per minute and she frequently vomited after episodes of coughing. A chest examination revealed absent breath sounds and Table 1: Serial blood results of the current case Investigation Day 0 Day 2 Day 3 Day 6 Hb level in g/dL 11.9 10.9 12.6 11.1 WCC x 109/L - 6.9 7.0 8.7 ANC x 109/L - 6.9 5.7 5.8 Lp level x 109/L - 0.7 0.7 1.6 PC x 109/L - 142 157 208 Sodium level in mmol/L 134 137 - 140 Potassium level in mmol/L 3.9 3.6 - 4.0 Urea level in mmol/L 1.5 - 1.4 1.2 Creatinine level in µmol/L 59 48 - 59 Anion gap in mmol/L 19 16 - 14 Bicarbonate level in mmol/L 17 19 - 20 ALT level in U/L - - 136 33 AST level in U/L - - 118 36 Bilirubin level in µmol/L - - 6 5 Hb = haemoglobin; WCC = white cell count; ANC = absolute neutro- phil count; Lp = lipoprotein; PC = platelet count; ALT = alanine aminotransferase; AST = aspartate transferase. Figure 1: Chest X-rays of a 22-year-old female patient with Mycoplasma pneumoniae pneumonia on (A) the day of admission and (B) two days later, showing worsening pleural effusion (arrow). Kowthar S. Hassan and Ghalib Al-Khadouri Case Report | e241 stony dullness involving the middle and lower chest. A repeat chest X-ray confirmed that the right-sided pleural effusion had worsened [Figure 1B]. Accord- ingly, a drainage procedure was performed, during which 2 L of exudative fluid consisting predominantly of lymphocytes (80%) was drained via a pigtail catheter over a 24-hour period. In view of her worsening condition, a nasopharyngeal aspirate sample was sent for serological and PCR testing. The PCR test results were positive for M. pneumoniae, while the serology was positive for IgA, IgM and IgG. As the serology test was qualitative, exact titres were not available. Treatment was continued with intravenous azithromycin for five days, after which the patient was discharged and advised to take moxifloxacin for six more days. She made a remarkable improvement and a chest X-ray four weeks later showed the complete resolution of the pneumonic patch and pleural effusion. Discussion Narita et al. described two types of M. pneumoniae- related pleural effusion with varying degrees of severity.14 The first is characterised by a benign transient chest disease, is most probably reactive as evidence of the M. pneumoniae genome is usually undetectable and has lower but still abnormal concentrations of interleukin (IL)-18 and IL-8. The second involves more persistent disease, contains M. pneumoniae DNA and has significantly higher IL-18 and IL-8 concentrations.14 It is possible that the presence of M. pneumoniae DNA elicits a stronger immunological reaction, thus causing greater lung damage and higher concentrations of IL-8 and IL-18. In addition, two major strains of M. pneumoniae clinical isolates have been reported to differ in adhesin gene sequence.15 Of these, type 2 is more virulent, causing respiratory epithelial destruction, and has a more robust biofilm, presumably conferring increased resistance to host defence mechanisms and antimicrobial penetration.15 In the current case, although the patient was not tested, it is likely that she had the more severe type with biofilm formation, especially as she did not improve following antimicrobial treatment. Drainage of the pleural effusion might have disrupted these biofilms, thereby aiding the recovery process. Thrombocytosis can occur as a feature of M. pneumoniae infection and probably represents an acute phase response, while thrombocytopenia is unusual.16 Another study found that children with severe M. pneumoniae pneumonia had prolonged fevers, higher C-reactive protein levels and lower lymphocyte and white cell counts (WCCs).17 The patients with segmental/lobar pneumonia were usually older and had a longer fever duration and lower WCC and lymphocyte counts compared with those with broncho- pneumonia.17 M. pneumoniae infections have also been associated with acute chest syndrome and haemolytic anaemia in patients with sickle cell anaemia.18 In the current case, the patient did not have haemolytic anaemia but did have the sickle cell trait. However, no particular association has been reported within this group in terms of the severity of the infection. The diagnosis of an M. pneumoniae infection can be difficult. The Gram staining of sputum samples is not feasible to identify mycoplasma bacterium due to the absence of a cell wall; moreover, a sputum culture is time-consuming because of the slow growth rate of the pathogen in vitro.1 Enzyme-linked immunoassay- based serology is the technique most frequently used to diagnose M. pneumoniae infections, although it can be confusing to interpret. Unfortunately, IgM antibodies can persist for months in some patients, thereby not necessarily indicating an acute infection, while others do not demonstrate an IgM response at all in cases of acute infection or reinfection.19,20 Moreover, while IgA is reported to be more sensitive than IgM in diagnosing acute infections in adults, Yamazaki et al. reported a lower sensitivity in young children.21,22 Therefore, the diagnosis of an M. pneumoniae infection relies on determining a four-fold increase in IgG titres taken two to four weeks apart.23 Spuesens et al. reported no obvious differences between PCR positivity rates in the throat swabs of individuals with suspected cases of M. pneumoniae infections and those of healthy subjects.24 This suggests that M. pneumoniae may colonise the upper airway without necessarily inducing disease. In the current case, the diagnosis of an M. pneumoniae infection was established by the IgA, IgM, IgG and PCR results of a nasopharyngeal swab. Furthermore, the patient’s positive response to azithromycin treatment following drainage of the pleural fluid supports this diagnosis. At SQUH, hospitalised patients with pneumonia are not routinely tested for M. pneumoniae; therefore, the current patient was tested only after she had deteriorated clinically. Nevertheless, the bacterial diagnosis of admitted cases of pneumonia is important, as patients with M. pneumoniae pneumonia require greater infection control measures for the duration of their illness, such as droplet isolation precaution measures.25 Although physicians tend to empirically treat patients requiring admission for atypical pneu- monia, testing for M. pneumoniae pneumonia might also allow for the better management of pleural effusion cases, should further intervention be required beyond antimicrobial therapy.13 Mycoplasma pneumoniae Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials Case report e242 | SQU Medical Journal, May 2018, Volume 18, Issue 2 Conclusion M. pneumoniae is a common cause of community- acquired pneumonia. Patients requiring hospital ad- mission should be tested for the presence of this bac- teria, especially if they have pleural effusion. a c k n o w l e d g e m e n t s The authors wish to acknowledge Dr. Hatem L. Farhan and Dr. Abdul H. Al-Hashim who were involved in the care of this patient. References 1. Holzman RS, Simberkoff MS. Mycoplasma pneumoniae and atyp- ical pneumonia. In: Bennett JE, Dolin R, Blaser MJ, Eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Dis- eases, 8th ed. Philadelphia, Pennsylvania, USA: Saunders, 2014. Pp. 2183–9. 2. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J 2004; 24:171–81. doi: 10.1183/09031936.04.00135703. 3. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17:697–728. doi: 10.1128/CMR.17.4.697-728.2004. 4. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI, Heijnen ML, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 2001; 183:675–8. doi: 10.1086/318529. 5. Klement E, Talkington DF, Wasserzug O, Kayouf R, Davidovitch N, Dumke R, et al. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis 2006; 43:1239–45. doi: 10.1086/508458. 6. Clyde WA Jr. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis 1993; 17:S32–6. 7. Fraley DS, Ruben FL, Donnelly EJ. Respiratory failure second- ary to Mycoplasma pneumoniae infection. South Med J 1979; 72:437–40. 8. Chiou CC, Liu YC, Lin HH, Hsieh KS. Mycoplasma pneu- moniae infection complicated by lung abscess, pleural effusion, thrombocytopenia and disseminated intravascular coagulation. Pediatr Infect Dis J 1997; 16:327–9. 9. Jayantha UK. Study on pleural effusions due to Mycoplasma pneumoniae infection. Sri Lanka J Child Health 2009; 34:5–6. doi: 10.4038/sljch.v34i1.562. 10. John SD, Ramanathan J, Swischuk LE. Spectrum of clinica and radiographic findings in pediatric mycoplasma pneumonia. Radiographics 2001; 21:121–31. doi: 10.1148/radiographics.21. 1.g01ja10121. 11. Jacobs E. Serological diagnosis of Mycoplasma pneumoniae infections: A critical review of current procedures. Clin Infect Dis 1993; 17:S79–82. doi: 10.1093/clinids/17.Supplement_1.S79. 12. Räty R, Rönkkö E, Kleemola M. Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR. J Med Microbiol 2005; 54:287–91. doi: 10.1099/jmm.0.45888-0. 13. Kaysin A, Viera AJ. Community-acquired pneumonia in adults: Diagnosis and management. Am Family Physician 2016; 94:698–706. 14. Narita M, Tanaka H. Two distinct patterns of pleural effusions caused by Mycoplasma pneumoniae infection. Pediatr Infect Dis J 2004; 23:1069. doi: 10.1097/01.inf.0000143655.11695.99. 15. Simmons WL, Daubenspeck JM, Osborne JD, Balish MF, Waites KB, Dybvig K. Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms. Microbiology 2013; 159:737–47. doi: 10.1099/mic.0.064782-0. 16. Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med 1993; 153:488–94. doi: 10.1001/archinte.19 93.00410040054008. 17. Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, et al. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr 2010; 10:48. doi: 10.1 186/1471-2431-10-48. 18. Neumayr L, Lennette L, Kelly D, Earles A, Embury S, Groncy P, et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics 2003; 112:87–95. 19. Thacker WL, Talkington DF. Analysis of complement fixation and commercial enzyme immunoassays for detection of anti- bodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2000; 7:778–80. doi: 10.1128/CDLI.7.5.778-780.2000. 20. Sillis M. The limitations of IgM assays in the serological diag- nosis of Mycoplasma pneumoniae infections. J Med Microbiol 1990; 33:253–8. doi: 10.1099/00222615-33-4-253. 21. Granström M, Holme T, Sjögren AM, Ortqvist A, Kalin M. The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and mu-capture IgM methods. J Med Microbiol 1994; 40:288–92. doi: 10.1099/00222615-40-4-288. 22. Yamazaki T, Narita M, Sasaki N, Kenri T, Arakawa Y, Sasaki T. Comparison of PCR for sputum samples obtained by induced cough and serological tests for diagnosis of Mycoplasma pneu- moniae infection in children. Clin Vaccine Immunol 2006; 13:708–10. doi: 10.1128/CVI.00413-05. 23. Gavranich JB, Chang AB. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Myco- plasma pneumoniae in children. Cochrane Database Syst Rev 2005; 20:CD004875. doi: 10.1002/14651858.CD004875.pub2. 24. Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: An observational study. PLoS Med 2013; 10:e1001444. doi: 10.1371/journal.pmed.1001444. 25. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35:S65–164. doi: 10.1016/j.ajic.2007.10.007. https://doi.org/10.1183/09031936.04.00135703 https://doi.org/10.1128/CMR.17.4.697-728.2004 https://doi.org/10.1086/318529 https://doi.org/10.1086/508458 https://doi.org/10.4038/sljch.v34i1.562 https://doi.org/10.1148/radiographics.21.1.g01ja10121 https://doi.org/10.1148/radiographics.21.1.g01ja10121 https://doi.org/10.1093/clinids/17.Supplement_1.S79 https://doi.org/10.1099/jmm.0.45888-0 https://doi.org/10.1097/01.inf.0000143655.11695.99 https://doi.org/10.1099/mic.0.064782-0 https://doi.org/10.1001/archinte.1993.00410040054008 https://doi.org/10.1001/archinte.1993.00410040054008 https://doi.org/10.1186/1471-2431-10-48 https://doi.org/10.1186/1471-2431-10-48 https://doi.org/10.1128/CDLI.7.5.778-780.2000 https://doi.org/10.1099/00222615-33-4-253 https://doi.org/10.1099/00222615-40-4-288 https://doi.org/10.1128/CVI.00413-05 https://doi.org/10.1002/14651858.CD004875.pub2 https://doi.org/10.1371/journal.pmed.1001444 https://doi.org/10.1016/j.ajic.2007.10.007